Skip to main content
Figure 1 | BMC Veterinary Research

Figure 1

From: Transcriptome and proteome analysis of tyrosine kinase inhibitor treated canine mast cell tumour cells identifies potentially kit signaling-dependent genes

Figure 1

Effect of masitinib on WST-1 conversion. Masitinib treatment (100 nM) reduced the metabolic activity of C2 cells by 54% after 24 hours of treatment. The metabolic activity further decreased up to 40% at 72 hours. Data shown represent the means+/−SD of five independent experiments with C2 cells, each performed in three to five wells.

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us